This is some text inside of a div block.
Deep TMS for major depression, interim post-marketing analysis of 1040 patients.
Steven A Harvey, Aron Tendler, Mark DeLuca, Jimmy Stehberg, Richard Naimark, David Schmidt, Owen Muir, Carlene McMillan, Saad Shakir, Todd Antin, Diana Ghelber, Walter Duffy, Natalie Lender, Michael Goodman, Moshe Isserles, Kenneth Melman, Juan Cabrera, Faisal A Munasifi, David Jones, Jagdeep Kaur, Irkali Mania, Sabeen Faris, Zeeshan Faruqui, Shahid Insaf, Deborah Kim, Susan Rushing, Brent Nelson, Abraham Zangen, Yiftach Roth
Deep TMS for depression isn't just a clinical trial result — it's a real-world practice story. This interim post-marketing analysis of over 1,000 patients documents high response and remission rates across community treatment sites, reinforcing the treatment's broad effectiveness.